Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome

Autor: Anca Mocofanescu, Suqian Lu, Mark Burton, Joy Ghosh, Richard M. Robb, Lee E. Goldstein, Maria Ericsson, Jer R. Kuszak, Rudolph E. Tanzi, Roberto Pineda, Robert D. Moir, Juliet A. Moncaster, Stephanie J. Soscia, Rebecca D. Folkerth, David G. Hunter, John I. Clark
Rok vydání: 2010
Předmět:
Male
Aging
Pathology
Light
lcsh:Medicine
Lens protein
0302 clinical medicine
Amyloid precursor protein
Scattering
Radiation

Child
lcsh:Science
Aged
80 and over

Multidisciplinary
Ophthalmology/Cataracts and Other Lens Disorders
biology
Molecular pathology
P3 peptide
Brain
Middle Aged
Pathology/Molecular Pathology
3. Good health
Fiber cell
Child
Preschool

Neurological Disorders/Cognitive Neurology and Dementia
Lens disorder
Female
Alzheimer's disease
Neurological Disorders/Alzheimer Disease
Research Article
Adult
medicine.medical_specialty
Adolescent
Molecular Sequence Data
Neuropathology
Cataract
Young Adult
03 medical and health sciences
Alzheimer Disease
Lens
Crystalline

mental disorders
medicine
Humans
Amino Acid Sequence
Eye Proteins
Protein Structure
Quaternary

Aged
Amyloid beta-Peptides
lcsh:R
medicine.disease
030221 ophthalmology & optometry
biology.protein
lcsh:Q
Down Syndrome
030217 neurology & neurosurgery
Zdroj: PLoS ONE, Vol 5, Iss 5, p e10659 (2010)
PLoS ONE
ISSN: 1932-6203
Popis: Down syndrome (DS, trisomy 21) is the most common chromosomal disorder and the leading genetic cause of intellectual disability in humans. In DS, triplication of chromosome 21 invariably includes the APP gene (21q21) encoding the Alzheimer's disease (AD) amyloid precursor protein (APP). Triplication of the APP gene accelerates APP expression leading to cerebral accumulation of APP-derived amyloid-beta peptides (Abeta), early-onset AD neuropathology, and age-dependent cognitive sequelae. The DS phenotype complex also includes distinctive early-onset cerulean cataracts of unknown etiology. Previously, we reported increased Abeta accumulation, co-localizing amyloid pathology, and disease-linked supranuclear cataracts in the ocular lenses of subjects with AD. Here, we investigate the hypothesis that related AD-linked Abeta pathology underlies the distinctive lens phenotype associated with DS. Ophthalmological examinations of DS subjects were correlated with phenotypic, histochemical, and biochemical analyses of lenses obtained from DS, AD, and normal control subjects. Evaluation of DS lenses revealed a characteristic pattern of supranuclear opacification accompanied by accelerated supranuclear Abeta accumulation, co-localizing amyloid pathology, and fiber cell cytoplasmic Abeta aggregates (approximately 5 to 50 nm) identical to the lens pathology identified in AD. Peptide sequencing, immunoblot analysis, and ELISA confirmed the identity and increased accumulation of Abeta in DS lenses. Incubation of synthetic Abeta with human lens protein promoted protein aggregation, amyloid formation, and light scattering that recapitulated the molecular pathology and clinical features observed in DS lenses. These results establish the genetic etiology of the distinctive lens phenotype in DS and identify the molecular origin and pathogenic mechanism by which lens pathology is expressed in this common chromosomal disorder. Moreover, these findings confirm increased Abeta accumulation as a key pathogenic determinant linking lens and brain pathology in both DS and AD.
Databáze: OpenAIRE